Clopidogrel 75 mg film-coated tablets

DRUG2 trials

Sponsors

Sint Antonius Ziekenhuis Stichting, Azienda Ospedaliera Universitaria Gaetano Martino Messina

Conditions

Chronic Coronary Syndrome in patients undergoing percutaneous coronary intervention (PCI)Coronary Artery DiseaseNon-ST-segment Elevation Acute Coronary Syndrome

Phase 3

A Randomized Controlled Study Evaluating Short-Term Dual Antiplatelet Therapy with Low-Dose Ticagrelor (60 mg) Followed by Monotherapy versus Standard-Duration Dual Antiplatelet Therapy with Clopidogrel in Patients with Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: the STELAR trial

Not yet recruitingCTIS2026-526368-18-00

Azienda Ospedaliera Universitaria Gaetano Martino MessinaChronic Coronary Syndrome in patients undergoing percutaneous coronary intervention (PCI)

Target: 500Updated: 2026-07-27

Phase 4

POPular GUILTY PILOT: Genotype-guided Clopidogrel monotherapy

RecruitingCTIS2024-518464-12-00

Sint Antonius Ziekenhuis StichtingCoronary Artery Disease, Non-ST-segment Elevation Acute Coronary Syndrome

Start: 2024-10-15Target: 200Updated: 2024-11-26